Evaluating intranasal fentanyl for pain management in pediatric emergencies
Evaluation of the "Intranasal Fentanyl" Protocol in Pediatric Surgical Emergencies at Strasbourg University Hospital
This study is testing if using intranasal fentanyl can effectively manage pain in children who come to the emergency room for musculoskeletal injuries.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 500 (estimated) |
| Ages | 1 Year to 17 Years |
| Sex | All |
| Sponsor | University Hospital, Strasbourg, France Academic / other |
| Locations | 1 site (Strasbourg) |
| Trial ID | NCT06832046 on ClinicalTrials.gov |
What this trial studies
This study examines the use of intranasal fentanyl for managing musculoskeletal pain in children treated at the pediatric emergency department of Strasbourg University Hospital. It aims to retrospectively assess the quality of fentanyl prescriptions and the monitoring of its administration in real-world clinical practice. By analyzing patient records from August 2022 to September 2024, the study seeks to gather insights on the effectiveness and safety of this pain management protocol in emergency settings.
Who should consider this trial
Good fit: Ideal candidates are children under 18 years old who received intranasal fentanyl for pain in the pediatric emergency department at Strasbourg University Hospital.
Not a fit: Patients who refuse participation or whose medical files are incomplete will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance pain management protocols for pediatric patients in emergency situations.
How similar studies have performed: Previous studies have validated the effectiveness and safety of intranasal fentanyl for pain management, suggesting a positive outlook for this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Child \< 18 years old * Child treated in the pediatric emergency department of Strasbourg University Hospital * Child who has benefited from intranasal fentanyl between 08/01/2022 and 09/31/2024. * Child (and/or his/her parental authority) who has not expressed, after information, his/her (their) opposition to the reuse of his/her health data for the purposes of this research. Exclusion Criteria: * Refusal of the child (and/or his/her parent) to participate in the study * Patient's medical file not incomplete * Child not domiciled in France.
Where this trial is running
Strasbourg
- Service d'Urgences Médico-Chirurgicales Pédiatriques - CHU de Strasbourg - France — Strasbourg, France (Recruiting)
Study contacts
- Study coordinator: Dimitar TCHOMAKOV, MD
- Email: Dimitar.tchomakov@chru-strasbourg.fr
- Phone: 33 3 88 12 81 18
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.